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Edited by Takashi GojoboriAbstract STAT4 is a transcription factor activated in response
to IL-12, and is involved in Th1 cell development. The molecular
mechanisms controlling the transcription of the STAT4 gene are
however, unclear. Sequence comparison of the 5 0 ﬂanking regions
of human, mouse and puﬀerﬁsh (Fugu rubripes) Stat4 genes
revealed a high frequency of Ikaros (Ik) binding elements in all
three species. We then investigated the role of Ik binding ele-
ments in the human STAT4 promoter using Jurkat T cells.
Transactivation, electrophoretic mobility shift assay and RNA
interference-mediated gene knockdown experiments revealed
that Ik is involved in the regulation of STAT4 in human T cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Gene regulation1. Introduction
The transcription factor STAT4 plays a pivotal role in cell-
mediated immune responses [1]. STAT4 is activated in
response to IL-12, and is involved in the development of naı¨ve
CD4+ T cells to the Th1 phenotype [2–4]. The requirement of
STAT4 in Th1 cell development has been conﬁrmed by tar-
geted-deletion of the Stat4 gene in mice [3,4]. Stat4 knockout
mice cannot mount type I T helper responses, and are defective
in the production of IFN-c in response to IL-12. In addition,
natural killer cell cytolytic function was severely impaired in
these mice.
Unlike other Stat genes which are ubiquitously expressed,
Stat4 shows speciﬁc expression. In human, the expression of
the STAT4 gene is restricted mainly to the spleen, heart, brain,
peripheral blood cells and testis [5]. Likewise, mouse Stat4
expression is restricted to the spleen, thymus, bone marrow,
lung, skeletal muscle and testis [6,7]. The expression of Stat4
protein is tightly and dynamically regulated in T cells, mono-
cytes, dendritic cells and macrophages [8,9]. In human T cells,Abbreviations: STAT, signal transducer and activator of transcription;
Ik, Ikaros; LPS, lipopolysaccharide; TSS, transcription start site;
RACE, rapid ampliﬁcation of cDNA ends; RT, reverse transcription;
UTR, untranslated region; siRNA, small interfering RNA; EMSA,
electrophoretic mobility shift assay; CNS, conserved non-coding seq-
uence; TFBS, transcription factor binding site
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vation of the cells with phytohemagglutinin [8]. In their basal
state, human monocytes do not express STAT4, but upon acti-
vation with IFN-c and LPS, both monocytes and monocyte-
derived dendritic cells, express high levels of STAT4 [9]. High
levels of STAT4 expression were also observed in vivo, in acti-
vated macrophages at sites of Th1-mediated inﬂammation [9].
Interestingly, recent studies have indicated that STAT4 may
play a potential role in human rheumatoid arthritis [9], and
the dysregulation of STAT4 expression may be associated with
the development and/or progression of a human disease, Sez-
ary syndrome [10].
Despite the importance of STAT4 in immune function, the
molecular mechanisms that regulate its expression remain un-
clear. To obtain insight into this issue, we used a comparative
genomics approach to identify conserved putative regulatory
elements. To increase the stringency for identifying these ele-
ments, we included the puﬀerﬁsh (Fugu rubripes) for sequence
comparisons. The puﬀerﬁsh, which is among the smallest ver-
tebrate genomes [11], has been shown to be useful for identify-
ing conserved regulatory elements [12].
We investigated the role of conserved regulatory elements in
the transcription of the STAT4 gene in T cells, and provide evi-
dence for the regulation of STAT4 by Ikaros (Ik), a hemato-
poietic zinc-ﬁnger transcription factor.2. Materials and methods
2.1. Isolation and sequencing of fugu Stat4 cosmid
The fugu genome database at http://www.fugu-sg.org (Third Assem-
bly) was BLAST searched with human STAT4 protein sequence using
TBLASTN algorithm, and a scaﬀold (#1520) containing putative
exons homologous to mammalian Stat4 exons, was identiﬁed. A pair
of primers (5 0-GCCCTTCAGTTTCTGGATGT-3 0, 5 0-GAGTTG-
AACTTCACTTCTCC-3 0) corresponding to these putative exons were
used in a PCR reaction to amplify a 485 bp fragment from fugu geno-
mic DNA. The PCR fragment was used as a probe to screen a gridded
genomic cosmid library (Greg Elgar, HGMP-RC, UK), and 11 posi-
tive cosmids were identiﬁed. One of the cosmids, 187L24 was chosen
and the ends of its insert were sequenced. The sequences of the insert
ends were then BLAST searched against the fugu genome database.
The two ends matched to diﬀerent scaﬀolds (#1520 and #1729) indicat-
ing that the two scaﬀolds are adjacent to each other. The gap between
the two scaﬀolds and the gaps within the scaﬀolds were ﬁlled by
sequencing using cosmid DNA as the template. A contiguous sequence
of about 40 kb, corresponding to cosmid 187L24 was obtained (sub-
mitted to GenBank under Accession No. AY458653). Genes on the
cosmid were identiﬁed by their homology to known genes, by BLAST
searching the databases at the National Center for Biotechnology
Information, USA.blished by Elsevier B.V. All rights reserved.
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Total RNA was prepared from fugu spleen and kidney; human
spleen, and Jurkat cells, using TRIzol reagent (Life Technologies,
USA). The transcription start site (TSS) and 3 0 end of fugu Stat4
and human STAT4 cDNA were determined by 5 0- and 3 0-rapid ampli-
ﬁcation of cDNA ends methods (RACE), with a SMART RACE kit
(Clontech, USA), using gene-speciﬁc primers. The exon and intron
boundaries of the fugu Stat4 gene were conﬁrmed by reverse transcrip-
tion (RT)-PCR. The exon–intron structure of the human STAT4 gene
was determined by mapping the reported human STAT4 cDNA se-
quence (Genbank Accession No. NM003151) to its genomic sequence
(http://genome.ucsc.edu/).
2.3. Plasmid constructs
Ik-expression vectors, CDM8-Ik-1 and CDM8-Ik-6, were gifts from
Dr. K. Georgopoulos [13,14]. The corresponding empty expression
vector CDM8, was prepared by digesting CDM8-Ik-1 with EcoRI,
to release a 1.8 kb insert containing the coding sequence for Ik-1.
The remaining 4.4 kb empty vector was then self-ligated.
To generate human STAT4 promoter-luciferase reporter constructs,
diﬀerent lengths of the human STAT4 promoter were ampliﬁed by
PCR from human BAC clone RP11-655H2 (CHORI, CA), using a ser-
ies of forward primers, and a common reverse primer that contained
KpnI sites at the 5 0 end. The forward primers were designed at
bp  3248, 1642, 1250, 922, 560, 356, 98, and +35, relative
to the TSS of the human STAT4 gene. The common reverse primer
was complementary to bp + 2781 to bp + 2803 in the human STAT4
gene. In addition, a fragment of the promoter devoid of the intron
in the 5 0-untranslated region (UTR), was generated by PCR using
the forward primer designed at bp  3248, and a reverse primer
complementary to bp + 13 to bp + 35 in the human STAT4 gene.
The PCR-generated promoter fragments were digested with KpnI
and cloned into the KpnI site of pGL3-basic plasmid vector (Promega,
USA). The recombinant human STAT4 promoter7 luciferase con-
struct clones were then sequenced to select for clones with the correct
orientation.
2.4. Cell culture
The T-cell derived cell line Jurkat was obtained from the American
Type Culture Collection. The cells were maintained in RPMI 1640
medium supplemented with 10% fetal calf serum, 2 mM glutamine,
100 U/ml penicillin, 100 lg/ml streptomycin and 1.5 g/ml sodium
bicarbonate at 37 C in a humidiﬁed atmosphere of 5% CO2 in air.
2.5. Transient transfections and luciferase assays
Jurkat cells were transfected by the DMRIE-C (Life Technologies,
USA) method, according to the manufacturers protocol. The transfec-
tion was carried out in 6-well plates, using 2 · 106 cells per well. Brieﬂy,
the cells were cotransfected with 4 lg of promoter-luciferase construct,
0.6 lg of pCMV b-gal, and up to 4 lg of Ik expression vectors. The to-
tal amount of DNA was kept constant by adding empty vector. After
48 h, the cells were harvested and lyzed in reporter lysis buﬀer (Prome-
ga, USA). Lysates were assayed for luciferase activity using the lucif-
erase assay kit (Promega, USA). b-Galactosidase activity was
measured using the b-Gal assay kit (Promega, USA), and used to nor-
malize levels of luciferase activity in the lysates.2.6. Semiquantitative RT-PCR analyses of STAT4 and Ik mRNA levels
Total RNA was isolated from Ik expression vector-transfected or
small interfering RNA (siRNA)-transfected Jurkat cells, using TRIzol
reagent, and cDNA was synthesized using ﬁrst strand cDNA synthesis
kit (Life Technologies, USA). The resultant cDNA product was then
used as a template in a PCR reaction, with Taq DNA polymerase (Life
Technologies, USA) and an appropriate pair of primers. The PCR
reaction conditions were individually optimized for each gene product
studied. For each gene product, the cycle number was optimized so
that the reaction fell within the linear range of product ampliﬁcation
(30 cycles for STAT4; 25 cycles for Ik; 30 cycles for Lck; 25 cycles
for GAPDH). STAT4 cDNA was ampliﬁed using a pair of primers
complementary to human STAT4 exon 2 (5 0-TCAAGTCCAACAGT-
TAGAAATCA-3 0) and exon 4 (5 0-TAAACAGTTTGAAATAACCA-
CAG-30). The cDNA of Lck was ampliﬁed by PCR using a pair of
primers complementary to human Lck exon 1 (5 0-ATCGATG-TGTGTGAGAACTGC-3 0) and exon 4 (5 0-GGACTGCGCCTTC-
CACCACTC-3 0). The PCR conditions for the ampliﬁcation of STAT4
cDNA and Lck cDNA were 95 C for 2 min, followed by 30 cycles of
95 C for 30 s, 50 C for 30 s and 72 C for 30 s, followed by a ﬁnal
elongation at 72 C for 5 min. The cDNAs of Ik isoforms were
PCR-ampliﬁed using a pair of primers complementary to human Ik
exon 2 (5 0-CCCCTGTAAGCGATACTCCAGATG-3 0) and exon 7
(5 0-GATGGCTTGGTCCATCACGTGGGA-3 0) [15]. The PCR con-
ditions for the ampliﬁcation of cDNAs of Ik isoforms were 95 C for
5 min, followed by 25 cycles of 94 C for 45 s, 63 C for 1 min and
72 C for 1 min [13]. Reverse-transcribed products of GAPDH were
measured for normalization, using 25 cycles of PCR, with a pair of
primers complementary to human GAPDH exon 8 (5 0-ACCA-
CAGTCCATGCCATCAC-3 0) and exon 9 (5 0-TCCACCACCCT-
GTTGCTGTA-3 0). Representative RT-PCR products were cloned
and sequenced to conﬁrm their sequences. The PCR products were
resolved by electrophoresis on 2% agarose gels containing ethidium
bromide, and photographed on a ultraviolet trans-illuminator (Strata-
gene, USA). The density of the human STAT4 or Ik transcripts in each
gel lane was quantiﬁed using Quantity One software (Biorad, USA),
and normalized to the density of RT-PCR ampliﬁed GAPDH frag-
ment. The resultant relative STAT4 or Ik transcript levels were ana-
lyzed statistically by Students t test.2.7. Western blot
Whole cell lysates were prepared from control siRNA or Ik-speciﬁc
siRNAtransfected Jurkat cells using ice-cold RIPA buﬀer, according
to the protocol described by the manufacturer (Santa Cruz Biotech-
nology, CA). Approximately 40 lg of whole cell lysate was electro-
phoresed along with prestained molecular weight markers on a 10%
SDS–polyacrylamide and the size-fractionated proteins were trans-
ferred onto a Hybond-C extra nitrocellulose membrane (Amersham
Biosciences, UK) using a Trans-blot semi dry transfer cell (Biorad,
USA). The membranes were blocked for 1 h at room temperature
in 1% non-fat dried milk, and then probed with either anti-actin
(Amersham Biosciences, UK), anti-Ik (anti-Ikaros H-100; Santa Cruz
Biotechnology, CA) or anti-STAT4 (anti-Stat4 L-18; Santa Cruz Bio-
technology, CA) antibody overnight at 4 C. The membranes were
then washed and probed with horse radish peroxidase-conjugated
secondary antibody for 1 h at room temperature and signals were
detected using SuperSignal West Pico Chemiluminescent Substrate
kit (Pierce, IL).2.8. RNA interference
RNA interference (RNAi) experiments with siRNA were carried out
according to a method previously described [16]. Ik-speciﬁc siRNA (5 0-
GUC GUG GCC AGU AAU GUU ATT-3 0) was designed using the
siDesign Centre computational program (Dharmacon Research Inc.,
USA) and synthesized by Dharmacon Research Inc. The Ik-speciﬁc
siRNA targets nucleotides 152–171 of human Ik relative to the ﬁrst
nucleotide of the start codon. As a negative control, a non-targeting
scrambled siRNA (Silencer Negative Control # 1siRNA; Ambion
Inc., TX) with no sequence homology to any known gene sequences
from human, mouse or rat, was used. Jurkat cells were transfected with
20 nM of Ik-speciﬁc siRNA or control siRNA for 48 h, using Gene
Silencer (Gene Therapy Systems, CA).2.9. Electrophoretic mobility shift assay
Double-stranded oligonucleotides were prepared by annealing equi-
molar amounts of complementary single-stranded oligonucleotides,
and 5 0 end-labeled with T4 polynucleotide kinase (New England Bio-
labs, USA). DNA–protein binding reactions were performed at room
temperature for 15 min in 20 ll gel shift reaction buﬀer containing
1 lg poly dI-dC, 0.5 ng of labeled probe and 10 lg of nuclear extract
from Jurkat cells (Santa Cruz Biotechnology, USA). In competition
experiments, a 5- to 500-fold molar excess of unlabeled oligonucleotide
was incubated with the reaction mixture prior to addition of the probe.
For antibody reactions, 2 lg of rabbit polyclonal anti-Ik antibody (anti-
Ikaros H-100; Santa Cruz Biotechnology, USA) was added to the
reaction mixture, prior to probe addition. In control binding reactions,
anti-Ik antibody was substituted with control rabbit serum. The DNA–
protein complexes were separated by electrophoresis on non-denaturing
4.5% polyacrylamide gels, and visualized by autoradiography.
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3.1. Genomic organization of the human, mouse and fugu Stat4
loci
We isolated a fugu cosmid, 187L24 and determined its com-
plete sequence. A total of ﬁve putative genes were identiﬁed in
the 40 kb fugu locus (Fig. 1A). The fugu Stat4 gene is ﬂanked
upstream by the Stat1 gene and downstream by the gene
encoding the fugu homolog of the human AK022607 protein
(fAK022607). Other genes in the locus include the ferroportin
gene (fFp), and a partial sequence of the gene encoding gluta-
minase (fGl). Examination of the human and mouse Stat4 loci
showed that both the human and mouse Stat4 gene are ﬂanked
upstream by the Stat1 gene and downstream by the myosin 1B
gene (Fig. 1A). However, the orientation of human and mouse
Stat1 genes is opposite to that of the fugu homolog. This indi-
cates that the Stat1 gene sequence has undergone a local inver-
sion in the ﬁsh or the mammalian lineage. The 5 0 intergenic
region of fugu Stat4 is 1.5 kb in length, whereas that of human
and mouse Stat4 is 100–130 kb (Fig. 1A).
The exon–intron boundaries in the human, mouse and fugu
Stat4 genes were found to be largely conserved and the fugu
Stat4 gene codes for a protein of 737 amino acids, which is
55.5% and 54.7% identical to human STAT4 and mouse Stat4,
respectively (data not shown).
The TSS of the human STAT4 gene in human spleen and
Jurkat cells was mapped by 5 0-RACE. The 5 0-RACE analysis
revealed the presence of a 2.7 kb intron in the 5 0-UTR and
mapped the TSS at 60 bp upstream of the intron (Fig. 1B).
By using a similar approach, the TSS of the fugu Stat4 genefGl fStat4 fAK0
Fugu
fStat1
6.0 kb
* * * *
*
Human STAT4 promoter
Fugu Stat4 promoter
A
B
STAT4STAT1GL
Human
1.5 kb
* ** *
4.0 kb
Mouse Stat4 promoter
mNab1
Mouse
mStat1 mStat4
Fig. 1. (A) Schematic representations of the human, mouse and fugu Stat4 l
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the human and mouse Stat4 loci was obtained from the UCSC Genome Br
human, mouse and fugu Stat4 promoter regions, depicting Ik binding eleme
positions of Ik core binding elements (GGGA or TCCC). Vertical thick line
elements (TGGGA(A/T) or (A/T)TCCCA). Splice donor and acceptor siteswas determined in fugu spleen and kidney, which showed a
high expression of Stat4 (data not shown). The 5 0UTR of
the fugu Stat4 contains a 112 bp intron, and the TSS is located
12 bp upstream of this intron (Fig. 1B).
3.2. Comparative sequence analysis reveals high frequency of Ik
binding elements in human, mouse and fugu promoters
In the search for conserved putative regulatory elements, the
sequence of human STAT4 and its ﬂanking intergenic regions
were compared with corresponding mouse and fugu sequences,
using the program MLAGAN [17]. Conserved non-coding se-
quences (CNSs) were identiﬁed as windows of at least 100 bp
with a minimal sequence identity of 70%. Human-mouse
sequence comparison showed numerous (>100) CNSs whereas
human-fugu comparison did not identify any CNS. No hu-
man-fugu CNSs were identiﬁed even when less stringent crite-
ria with a minimal window size of 40 bp and a sequence
identity of >60%, were used (data not shown). However, when
we scanned the promoter regions of human, mouse and fugu
Stat4 for putative transcription factor binding sites (TFBSs)
by using the MatInspector program [18], a high frequency of
Ik binding elements were detected in all three promoters (Figs.
1B and 2). A high frequency (four high aﬃnity and 18 core for
human; one high aﬃnity and 13 core for mouse) of Ik binding
elements was found within a region 1.5 kb upstream of the TSS
of human and mouse Stat4 (Figs. 1B and 2). A total of 21 Ik
core binding elements (GGGA) and one high aﬃnity Ik bind-
ing element (TGGGA(A/T)) [13] was found 1.4 kb upstream of
the TSS of fugu Stat4 (Fig. 1B). The overall frequency of
occurrence of Ik binding elements in the Stat4 promoter region22607
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ATG
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600 kb
800 kb
mMy
oci. Arrows represent genes and indicate the direction of transcription.
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owser (http://genome.ucsc.edu/). (B) Schematic representations of the
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s with an asterisk above, indicate positions of high aﬃnity Ik binding
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Fig. 2. Sequence of the human STAT4 promoter region. Numbers indicate the positions relative to the TSS (bent arrow). Putative TFBSs are
underlined. TFBSs conserved between human and mouse are double underlined. AP1, activator protein 1 binding element; GATA1, GATA binding
factor 1 binding element; GAS, interferon c-activated sequence; GFI1, growth factor independence 1 binding element; Ik, ikaros core binding
element; Ik*, high aﬃnity ikaros binding element; RBPJK, recombination signal-binding protein of Jkappa binding element; Sp1, simian-virus-40-
protein-1 binding element.
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Fig. 3. Eﬀect of Ik-1 on human STAT4 promoter activity in Jurkat cells. The activities of diﬀerent luciferase reporter constructs cotransfected with
CDM8 empty vector or Ik-1 expression vector CDM8-Ik-1, were determined in Jurkat cells. The left panel shows a schematic representation of
luciferase reporter gene constructs. The TSS is indicated by a bent arrow. Positions of Ik binding elements are indicated in a similar manner as in
Fig. 1. The right panel shows the relative luciferase activity of the corresponding constructs cotransfected with CDM8 (vector) or CDM8-Ik-1 (Ik-1),
48 h after transfection. The luciferase activity was normalized to b-galactosidase activity, and calculated relative to the activity of pGL3-basic
cotransfected with empty vector, which was set arbitrarily at 1.0. The data shown are from a representative experiment reported as the
mean(n = 3) ± standard error of the mean. Asterisks indicate that the mean activity of the construct cotransfected with CDM8-Ik-1 is signiﬁcantly
(P < 0.01) diﬀerent from the same construct cotransfected with CDM8 empty vector, and numbers in brackets above the asterisk indicate fold
diﬀerence.
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Fig. 4. EMSA of a high aﬃnity Ik binding site within the human STAT4 promoter. (A) Three oligonucleotides designated SIK, mSIK and conIK,
were used in the EMSAs. Ik-binding elements are underlined. The oligonucleotide SIK contained the human STAT4 promoter sequence from
bp  133 to bp  108, with a high aﬃnity Ik binding element. The oligonucleotide mSIK is identical to SIK, except for mutations within the Ik
binding element as indicated in boldface. The oligonucleotide conIK is a consensus Ik binding sequence that has two Ik binding elements. (B) EMSAs
were carried out using the labeled SIK oligonucleotide as the probe, in the presence of Jurkat nuclear extract and various unlabeled competitor
oligonucleotides in molar excess, as indicated. Retarded bands (C1 and C2), are indicated by arrows. (C) EMSAs were carried out using SIK
oligonucleotide as probe, in the presence of Jurkat nuclear extract and anti-Ik antibody or control rabbit serum, as indicated.
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nucleotide distribution, for fugu, human and mouse, respec-
tively. The presence of such a high frequency of putative Ik
binding elements within the human, mouse and fugu promot-
ers, prompted us to investigate the role of Ik binding elements
in the regulation of the human STAT4 gene.
Analysis of the human-mouse CNS found within 1.5 kb of
the TSS of human STAT4, showed conservation for one
AP1, one NFAT, one GAS and two Ik binding elements
(Fig. 2). Thus, only two of the 22 putative Ik binding elements
identiﬁed in the human STAT4 promoter appears to be con-
served between human and mouse. The remaining Ik binding
sites might have evolved independently in the two lineages or
might have originated in a common ancestor and then shifted
in one of the lineages due to sequence turnover, insertions or
deletions.
3.3. Ik-1 transactivates the human STAT4 promoter
To ascertain the functional signiﬁcance of the putative Ik
binding elements in the human STAT4 promoter, a series
of STAT4 promoter-luciferase constructs with deﬁned dele-
tions, were made (Fig. 3) and cotransfected into Jurkat cells
with an Ik-1 expression vector (CDM8-Ik1) or empty vector.
Cotransfection of the deletion constructs with empty vector,
showed that progressive deletion of the promoter from posi-
tion 1250 to position 98, relative to the TSS, broughtabout a gradual increase in basal promoter activity (Fig. 3).
Examination of this region (position 1250 to position
98) showed the presence of one GFI1 and two RBPJK
putative binding elements (Fig. 2). As the corresponding tran-
scription factors that bind these elements are known to act as
transcriptional repressors, removal of these elements by dele-
tion may have contributed to increased basal promoter activ-
ity. Further deletion of the region from 98 to +35, however
abolished basal promoter activity. Interestingly, removal of
the 2.7 kb 5 0-UTR intron from the promoter (construct P-
3248DI), resulted in marked increase in basal promoter activ-
ity compared with the intact promoter (construct P-3248),
suggesting that the 5 0-UTR intron may have repressor
elements that modulate basal activity. Examination of the
5 0-UTR intron for putative TFBSs revealed the presence of
one BCL6, two E4BP4, three GFI1, one RBPJK and one
ZF-5 putative binding elements (data not shown), whose cor-
responding transcription factors have been reported to have
repressive eﬀects. These TFBSs may play a role in the repres-
sive eﬀect of the 5 0-UTR intron. Luciferase activity was sig-
niﬁcantly enhanced for several deletion constructs when
they were cotransfected with Ik-1 expression vector, com-
pared with empty vector (Fig. 3). The deletion of the pro-
moter from position 3248 to position 1642, resulted in a
slight increase in Ik-1-mediated activation of the promoter.
Progressive deletion of the region from 1642 to 356, led
Fig. 5. Eﬀect of Ik-1 on endogenous STAT4 transcript levels in Jurkat
cells. (A) Semiquantitative RT-PCR analysis of STAT4 transcript
levels. Jurkat cells were transfected with 4 lg of Ik-1 expression vector
CDM8-Ik-1 (Ik-1) or CDM8 empty vector (vector) for 48 h. Total
RNA was extracted from equal amounts of Jurkat cells. Thereafter,
the RNA was reverse transcribed and cDNA was subjected to PCR
using gene-speciﬁc primers for STAT4 and GAPDH. GAPDH was
used for normalization. rt, RT-PCR performed using Jurkat total
RNA reverse-transcribed in absence of reverse transcriptase. (B)
Relative STAT4 transcript levels quantiﬁed by densitometric scan.
Open bars represent mean values of STAT4 transcript level from three
independent experiments, done using diﬀerent preparations of total
RNA. Asterisk above the error bar indicates that the STAT4 transcript
level is signiﬁcantly (P < 0.01) diﬀerent from vector control.
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fold to 1.5-fold, suggesting that several Ik binding elements
within this region may be involved in the activation of the
promoter. The Ik-1-mediated activation of the promoter
was completely abolished, upon deletion of the promoter
from position 356 to position 98. Since this region has ﬁve
Ik core binding elements and one high aﬃnity Ik binding ele-
ment (Figs. 1B and 2), one or more of these elements may be
involved in Ik-1-mediated activation. Removal of the 5 0 UTR
intron in the STAT4 promoter (construct P-3248DI) did not
signiﬁcantly reduce the Ik-1-mediated activation, when com-
pared to the intact promoter (construct P-3248). Interestingly,
this intron contains one high aﬃnity and several core Ik
binding elements (data not shown). Our results suggest that
these elements do not contribute to the activation of the
promoter. The activation of the STAT4 promoter (construct
P-1642) by Ik-1 was also found to be dose-dependent, with a
maximum of 2.7-fold activation attained by cotransfecting
4 lg of Ik-1 expression vector (data not shown). In contrast,
cotransfection of construct P-1642 with the Ik-6 expression
vector, which encodes a dominant-negative isoform of Ik
[14], repressed promoter activity by a modest but signiﬁcant
30% (data not shown), suggesting that endogenous Ik in Jur-
kat cells binds to the STAT4 promoter of construct P-1642
and contributes to its activity. Taken together, these results
provide evidence that the STAT4 promoter contains func-
tional Ik binding elements, responsive to Ik-1-mediated acti-
vation. Interestingly, cotransfection of a 1.4 kb fugu Stat4
promoter-luciferase construct with Ik-1 expression vector into
Jurkat cells also resulted in a signiﬁcant 1.5-fold increase,
compared with cotransfection with empty vector (data not
shown), suggesting that Ik binding elements in the fugu pro-
moter are recognized by mammalian Ik-1.
3.4. Ik binds to the human STAT4 promoter in vitro
Electrophoretic mobility shift assays (EMSAs) were per-
formed to determine protein binding at a putative high aﬃnity
Ik binding element located at position 124 to 119, within
the human STAT4 promoter. Three oligonucleotides, SIK,
mSIK and conIK, were synthesized and used in the EMSAs
(Fig. 4A). The labeled oligonucleotide SIK, which contained
the putative high aﬃnity Ik binding element (TGGGAA),
bound proteins from Jurkat nuclear extract, with formation
of two major protein–DNA complexes, C1 and C2 (Fig. 4B,
lane 2). Complex C1 could be competed away completely by
excess unlabeled SIK, suggesting a sequence-speciﬁc interac-
tion (Fig. 4B, lanes 3–5). In contrast, complex C2 was not
competed away by excess unlabeled SIK (Fig. 4B, lanes 3–5),
suggesting that it is a non-speciﬁc complex. The addition of ex-
cess unlabeled consensus Ik binding sequence (conIK) [13] also
disrupted formation of complex C1 (Fig. 4B, lane 7), whereas
the cold competitor mSIK, with mutations in the high aﬃnity
Ik binding element, did not (Fig. 4B, lane 6). Furthermore,
when an anti-Ik antibody was added to the reaction mixture,
the formation of complex C1 was diminished, indicating a dis-
ruption of Ik–DNA interaction by this antibody (Fig. 4C, lane
3). In contrast, no disruption of complex C1 was observed
when control serum was added (Fig. 4C, lane 4). In addition,
anti-Ik antibody had no eﬀect on the formation of the non-
speciﬁc complex C2 (Fig. 4C, lane 3). Taken together, these
ﬁndings demonstrate the in vitro binding of Ik to the human
STAT4 promoter.3.5. Ik-1 enhances endogenous STAT4 expression in Jurkat cells
To determine if Ik-1 overexpression could enhance endoge-
nous STAT4 mRNA levels in Jurkat cells, the cells were trans-
fected with Ik-1 expression vector (CDM8-Ik-1) or empty
vector, and STAT4 transcript levels were measured by semi-
quantitative PCR. STAT4 mRNA levels were found to be en-
hanced in Ik-1 vector-transfected cells, compared with cells
transfected with empty vector (Fig. 5A). Quantiﬁcation of
STAT4 mRNA levels revealed a signiﬁcant 1.9-fold diﬀerence
between Ik-1 vector- and empty vector-transfected cells
(Fig. 5B). Overexpression of Ik-1 therefore, enhanced endoge-
nous STAT4 expression in Jurkat cells.
3.6. Ik-speciﬁc siRNA attenuates endogenous STAT4 expression
in Jurkat cells
To determine if reduction in Ik expression could attenuate
endogenous STAT4 mRNA levels in Jurkat cells, the cells were
transfected with Ik-speciﬁc siRNA or control non-targeting
siRNA, and Ik and STAT4 transcript levels were measured.
Transfection of Ik-speciﬁc siRNA into Jurkat cells resulted
in a reduction in the expression of Ik-1, Ik2/3, and STAT4
mRNA, compared with control siRNA (Fig. 6A). Ik-speciﬁc
siRNA had no signiﬁcant eﬀect on the expression of another
endogenous gene, Lck (Fig. 6A), suggesting a speciﬁc eﬀect
Fig. 6. Eﬀect of Ik-speciﬁc siRNA on endogenous STAT4 gene expression in Jurkat cells. (A) Semiquantitative RT-PCR analysis of STAT4 and Ik
transcript levels. Jurkat cells were transfected in the presence of 20 nM Ik-speciﬁc siRNA (+Ik-siRNA) or control siRNA (+Ctrl-siRNA) for 48 h.
Total RNA was extracted from equal amounts of Jurkat cells. Thereafter, the RNA was reverse transcribed and cDNA was subjected to PCR using
gene-speciﬁc primers for STAT4, Ik, Lck and GAPDH. GAPDH was used for normalization. Products of human cDNAs Ik-1 (890 bp), Ik-2 (629 bp),
Ik-3 (629 bp) and Ik-4 (503 bp) were detectable. The 750 bp product (indicated by an asterisk) detected is an artifact representing Ik-1/Ik-2 and Ik-1/
Ik-3 hybrid molecules. GAPDH was used for normalization. rt, RT-PCR performed using Jurkat total RNA reverse-transcribed in absence of
reverse transcriptase. (B) Relative STAT4 and Ik isoform transcript levels quantiﬁed by densitometric scan. Open bars represent mean values of
STAT4 or Ik isoform transcript level from three independent experiments. Asterisk indicates that the STAT4 or Ik isoform transcript level is
signiﬁcantly (P < 0.01) diﬀerent from Jurkat cells transfected in the presence of control-siRNA. (C) Western blot analysis of STAT4 and Ik protein
levels. Jurkat cells were transfected in the presence of 20 nM Ik-speciﬁc siRNA (+Ik-siRNA) or control siRNA (+Ctrl-siRNA) for 48 h. The
positions of molecular weight markers and Ik isoforms are indicated.
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Jurkat cells also resulted in a reduced expression of Ik-1 and
Ik2/3 protein levels compared with control siRNA, while no
signiﬁcant eﬀect was observed with actin levels, as shown by
Western blot analysis (Fig. 6C), showing that silencing of the
Ik gene resulted in knock-down of targeted Ik protein.
Together with the observed reduction in Ik protein levels,
the level of endogenous STAT4 protein in Ik-speciﬁc siRNA-transfected cells was also reduced compared with control siR-
NA-transfected cells (Fig. 6C). Quantitation of mRNA levels
showed a signiﬁcant reduction of Ik-1 and Ik-2/3 transcript
level by 70% and 40%, respectively, in siRNA-transfected cells
compared with cells transfected with control siRNA (Fig. 6B).
The level of endogenous STAT4mRNA in Ik-siRNA-transfec-
ted cells was reduced signiﬁcantly by 65% compared with
control siRNA-transfected cells (Fig. 6B). Thus, the reduction
W.-H. Yap et al. / FEBS Letters 579 (2005) 4470–4478 4477in Ik expression attenuated STAT4 expression both at mRNA
and protein levels in Jurkat cells.4. Discussion
In this paper, we present the ﬁrst evidence for the transcrip-
tional regulation of the human STAT4 gene by Ik, a hematopoi-
etic zinc ﬁnger transcription factor that plays a central role in
lymphoid and erythroid diﬀerentiation [19,20]. We identiﬁed a
high frequency of putative binding sites for Ik in the regulatory
region adjacent to the basal promoter of STAT4 that was also
conserved in the mouse and fugu promoters. Transactivation,
EMSAs and RNAi-mediated gene knockdown experiments re-
vealed the involvement of Ik in the regulation of STAT4.
A total of four high aﬃnity Ik binding elements, together with
18 Ik core binding elements were found within 1.5 kb upstream
of the TSS of the human STAT4 gene (Figs. 1B and 2). Ik is
known to act both as an activator and repressor of transcription
[21]. Our results indicate that Ik plays a transactivating role with
regards toSTAT4. Interestingly, it has been reported that Ik can
bind with low aﬃnity to some but not all Ik binding elements
within the mouse immunoglobulin heavy chain c1 and e promot-
ers, and that the binding of Ik is enhanced when several binding
elements are present, indicating cooperative binding [22]. It is
not known if all the putative Ik binding elements in the STAT4
promoter are functional binding sites. The complete character-
ization of all the Ik elements in the STAT4 promoter will be
the subject of further work.
The Ik gene encodes seven exons, and can generate multiple
isoforms by alternative splicing [20]. Given the presence of var-
ious Ik isoforms, as well as other members of the Ik family
(such as Aiolos and Helios) in T cells [23], it is possible that be-
sides Ik-1, other DNA-binding Ik isoforms (Ik-2 and Ik-3) and
members of the Ik family, may participate in regulation of the
STAT4 gene. Although our experiments show binding of Ik to
STAT4 promoter sequences in vitro, further work is required
to verify if Ik binds to STAT4 in vivo. In addition to Ik bind-
ing elements, analysis of the STAT4 promoter revealed the
presence of other putative transcription regulatory elements
such as AP1, GATA1, GFI1, NFAT, GAS, RBPJK and Spl
elements (Fig. 2). Of these elements, an AP1, an NFAT and
a GAS element was found to be conserved between human
and mouse (Fig. 2). It has been reported that Ik may act
together with other transcription factors to modulate promoter
activity [24,25]. For instance, Ik-2 and upstream stimulatory
factor has been reported to synergize in transactivating the
promoter of the mouse d-opiod receptor gene [25]. The rele-
vance of other putative conserved regulatory elements in the
STAT4 promoter, to the Ik-mediated control of STAT4
promoter activity will be the subject of further investigation.
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